SPONSORED
Zantac Has Been Linked to Cancer: Find Out Your Zantac Cancer Risk by Taking This Short Quiz!
Feb 20, 2020, 4:04 PM | Updated: Feb 21, 2020, 2:48 pm
This article about your Zantac cancer risk is sponsored by Robert J Debry.
Are you at risk of cancer from using Zantac as your anti-indigestion over the counter medication of choice? On September 13, 2019, the FDA issued a warning that the heartburn medicine Zantac contains the cancer-causing chemical NDMA. Zantac has recently been linked to cancer, but what are your risk factors? You can take this short quiz to see if you are at risk of cancer from your use of Zantac.
Have you used Zantac?
Did you take a generic version of Zantac?
Do you take either Zantac or the generic more than twice a week?
Do you take Zantac as a long-term solution for heartburn?
Have you talked to your doctor about using Zantac?
Have you tried alternative over-the-counter medications besides Zantac?
Have the alternative over-the-counter medications worked?
Have you experienced any of the following: weight loss, bloody or tarry stools symptoms of anemia like fatigue and weakness, or abdominal pain worse than you normally experience?
Do you have a family history of cancer?
Do you have additional cancer risk factors like a history of smoking?
Share your Results:
If you scored moderate or high for your risk of cancer, contact your doctor. If you or a loved one took Zantac or a generic version, you might be entitled to compensation.
The contents of this article are for informational purposes only. The program is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website!
KSL does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on the program. Reliance on any information provided in this article is solely at your own risk.